- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04771208
I Kua na'u Advance Care Planning for Native Hawaiian Elders
I Kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders - Trial Phase
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project entitled, "I kua na'u" in Hawaiian, translates to "Let me carry out your last wishes." This work aims to honor the Native Hawaiian (NH) sense of cultural context for initiating a conversation between elders and their families through a video intervention to promote Advance Care Planning (ACP) in a manner that respectfully communicates the personal preferences of NH elders to their family, caregivers and the health care system. The full I kua na'u program will examine a video enhanced intervention designed by and for Native Hawaiians (NH) and their family caregivers in three distinct settings: 1) NH Homesteads, 2) Assisted Living, and 3) Ambulatory Clinics. The overall objective of the present proposal is to conduct the first phase of the program, which covers the planned two year development period of the I kua na'u ACP video program. During this time, we will conduct a series of focus groups and one-on-one stakeholder interviews to inform the creation of: A) NH ACP videos; B) a NH personal video declaration process; and, C) NH community members training program to deliver the intervention.
Native Hawaiians (NHs), the indigenous people of Hawai'i, comprise a diverse population of more than 500,000 individuals living in the US and are one of the fastest growing racial/ethnic groups in the country. The highest concentration (55%) of NHs live in the State of Hawai'i, the ancestral home of all NH people. Several studies have established a higher mortality rate among NHs that occurs at an age 10-15 years earlier than the general US population. A recent study found that NHs had the lowest life expectancy of the five major ethnic groups in the state of Hawai'i, with a consistent 10-year gap between NHs and the longest living ethnic group. According to the US Census 2010, ~100,000 NHs over the age of 50 currently live in the US with 60% residing in the State of Hawai'i. Yet few studies have examined the use of end-of-life care and advance care planning in NHs who are at high risk for more frequent and earlier age death. Thus, this proposal aims to fill the gap in our understanding of ACP among NH elders and will develop, test and disseminate a culturally informed intervention to improve ACP practices among NH elders and their families.
Mounting evidence suggests that NHs rarely participate in ACP or communicate their ACP wishes to their families, who are often the primary caregivers. Palliative care and hospice services have been associated with less intensive interventions at the end of life, possibly due to improved communication and decision making. Learning about ACP and communicating with family and providers is the best way for a person to get health care that is concordant with one's wishes and values. NHs represent a unique population with distinct cultural, epidemiological, genetic, and psychosocial characteristics. Evidence suggests that they also have distinct health care and health communication preferences. Although some of these distinct features and preferences may contribute to disparities in health care for NHs with advanced illness, these disparities may also be due to identified health communication gaps.
While the topic of ACP communication specifically is understudied, critical health communication gaps exist for many NHs. Previous research by members of this study team and others have identified relevant health communication challenges in NH communities. For instance, practical challenges included jargon and lack of plain English. Interpersonal issues included doctors rushing, doctors not assessing comprehension, and doctors not treating respondents as people. Respondents noted that they would often not ask questions even when they knew they did not understand because they did not want the provider to think negatively of them. Overarching themes to improve communication gaps included: the importance of family and community in health information dissemination, the importance of personal experience and relationships to the salience of health information, and the desire for local cultural relevance in health communication.
ACP seeks to ensure that patients receive medical care consistent with their values, goals and preferences during the advanced stages of a disease when they no longer have capacity to make decisions. ACP is the most consistent factor associated with better end-of-life outcomes in patients with advanced illness and their caregivers. The lack of ACP is associated with more aggressive interventions, more terminal hospitalizations, lower hospice use, and worse caregiver burden and family bereavement outcomes. Unfortunately, ACP completion remains inadequate, and has remained consistently low. Studies show that traditional written and verbal ACP does not effectively inform many patients and caregivers, and often occurs late in the disease process, which is especially true in vulnerable communities such as NHs. Other common barriers to ACP include lack of tailoring for NHs, variable quality of clinician communication, complex relationships between families and clinicians regarding decision making, and the inability for patients to realistically envision accurate future health states. These barriers present challenges as well as an opportunity. This opportunity for change is a major goal of this proposal to evaluate not just an intervention and its meaningfulness to individuals, caretakers, and family, but also, to educate and train our communities on how to deploy the intervention in real world settings. Individuals from our NH communities will be trained to carry out the intervention and to implement this training using our community peer-to-peer model.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96822-2234
- University of Hawaii
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Subject Inclusion criteria:
- NH adult > 55 years of age;
- Pre-existing relationship with a primary care provider (PCP, minimum of two prior visits to PCP);
- Referral by collaborating community organization.
Subject Exclusion Criteria:
- inability to view videos due to visual impairment (worse than 20/200 corrected);
- psychological state not appropriate for ACP discussions as determined by RA or clinician;
- cognitive impairment (≥2 errors) as assessed by the validated Short Portable Mental Status Questionnaire.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Pre-Post Trial
Native Hawaiian participants from Homestead and Group Assisted Living (N=110) will partake in a pre-post study design.
Participants will receive a baseline survey (as described below), view the ACP video intervention, and receive a post-intervention survey, which includes the same items as the baseline survey.
In-person or phone interviews will be done at three and six months.
|
A combination of Native Hawaiian advance care planning video decision support tool and personalized video declarations shared with providers and family members.
|
|
No Intervention: Randomized Clinical Trial: Control Group
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm.
The control group will receive usual care.
All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey.
Follow-up in person or by phone interviews will be done at three and six months.
|
|
|
Experimental: Randomized Clinical Trial: Intervention Group
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm.
The intervention group will use the ACP video decision aid.
All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey.
Follow-up in person or by phone interviews will be done at three and six months.
|
A combination of Native Hawaiian advance care planning video decision support tool and personalized video declarations shared with providers and family members.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in ACP Knowledge (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Six questions regarding knowledge of ACP which were used and validated in previous studies will be asked.
A score of 0-6 will be assigned.
Higher scores indicate more knowledge.
Questions will be asked before and after the intervention is administered.
|
Baseline, 6 weeks, 3 months, 6 months
|
|
Change in ACP Knowledge (RCT)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Six questions regarding knowledge of ACP which were used and validated in previous studies will be asked.
A score of 0-6 will be assigned.
Higher scores indicate more knowledge.
|
Baseline, 6 weeks, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in End of Life Health Care Preferences (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Participants will be asked 2 questions about their end of life health care preferences.
Any change in response will be coded as a change.
Questions will be asked before and after the intervention is administered.
|
Baseline, 6 weeks, 3 months, 6 months
|
|
Change in Decisional Conflict (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Decisional conflict will be measured with a 2 question survey that returns a score of 0-10.
Higher scores indicate more conflict.
Questions will be asked before and after the intervention is administered.
|
Baseline, 6 weeks, 3 months, 6 months
|
|
Change in Advance Care Planning Engagement (Pre-Post Trial)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Four validated likert scale questions regarding ACP engagement are averaged to return an overall score of 0-5.
Higher scores indicate increased engagement.
Questions will be asked before and after the intervention is administered.
|
Baseline, 6 weeks, 3 months, 6 months
|
|
Change in End of Life Health Care Preferences (RCT)
Time Frame: Baseline, 6 weeks, 3 months, 6 months
|
Participants will be asked 2 questions about their end of life health care preferences.
Any change in response will be coded as a change.
Comparison will be post-intervention vs control.
|
Baseline, 6 weeks, 3 months, 6 months
|
|
Change in Decisional Conflict (RCT)
Time Frame: Baseline, six weeks, 3 months, 6 months
|
Decisional conflict will be measured with a 2 question survey that returns a score of 0-10.
Higher scores indicate more conflict.
Comparison will be post-intervention vs control.
|
Baseline, six weeks, 3 months, 6 months
|
|
Change in Advance Care Planning Engagement (RCT)
Time Frame: Baseline, six weeks, 3 months, 6 months
|
Four validated likert scale questions regarding ACP engagement are averaged to return an overall score of 0-5.
Higher scores indicate increased engagement.
Comparison will be post-intervention vs control.
|
Baseline, six weeks, 3 months, 6 months
|
|
Consumer Assessment of Healthcare Providers and Systems Survey (RCT)
Time Frame: 6 weeks post enrollment
|
11 questions from the validated AHRQ survey that asks patients to report on their experiences with providers and staff in primary care settings.
|
6 weeks post enrollment
|
|
Consumer Assessment of Healthcare Providers and Systems Survey (Pre-Post Trial)
Time Frame: 6 weeks post enrollment
|
11 questions from the validated AHRQ survey that asks patients to report on their experiences with providers and staff in primary care settings.
|
6 weeks post enrollment
|
|
Video Preferences (RCT)
Time Frame: 6 weeks post enrollment
|
4 questions to determine the participant's level of comfort in watching the video.
|
6 weeks post enrollment
|
|
Video Preferences (Pre-Post Trial)
Time Frame: 6 weeks post enrollment
|
4 questions to determine the participant's level of comfort in watching the video.
|
6 weeks post enrollment
|
|
ACP Documentation (RCT)
Time Frame: 12 months post enrollment
|
2 questions about whether the participant has had a conversation about ACP with either a provider or a friend/family member, as well as a EHR review for specific documentation of ACP preferences (intubation, DNR, dialysis, POLST, health care proxy).
|
12 months post enrollment
|
|
ACP Documentation (Pre-Post Trial)
Time Frame: 12 months post enrollment.
|
2 questions about whether the participant has had a conversation about ACP with either a provider or a friend/family member.
|
12 months post enrollment.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Paasche-Orlow, MD, MPH, Tufts Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-41343
- 1R01NR018400 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advance Care Planning
-
Southcentral FoundationUniversity of Colorado, Denver; University of Washington; University of Arkansas and other collaboratorsRecruiting
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingAdvance Care PlanningUnited States
-
University of PittsburghCompletedAdvance Care PlanningUnited States
-
The University of Hong KongNot yet recruitingAdvance Care Planning
-
King's College LondonPrincess Alice HospiceCompleted
-
Duke UniversityCompletedAdvance Care PlanningUnited States
-
Southcentral FoundationUniversity of Colorado, Denver; University of Washington; Washington State University and other collaboratorsCompletedAdvance Care PlanningUnited States
-
Liverpool University Hospitals NHS Foundation TrustUniversity of LiverpoolCompleted
-
Duke UniversityCompletedAdvance Care PlanningUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Aging (NIA); Sound PhysiciansCompletedAdvance Care PlanningUnited States